Atlas Trials

Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer

Clinical trial NCT05963490 · RECRUITING

Trial details

NCT number
NCT05963490
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Microsatellite Stable Metastatic Colorectal Cancer
Start date
2023-04-25
Primary completion
2025-04-25
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.